Predictors and the Subsequent Risk of End-Stage Renal Disease – Usefulness of 30% Decline in Estimated GFR over 2 Years

• Wen Xiu Chang,

  Affiliations Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, Department of Nephrology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Shinichiro Asakawa,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Daigo Toyoki,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Yoshikazu Nemoto,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Chikayuki Morimoto,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Yoshifuru Tamura,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Tatsuru Ota,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Shigeru Shibata,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Yoshihide Fujigaki,

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Zhong Yang Shen,

  Affiliation Department of Organ Transplantation, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Shunya Uchida

  * E-mail: s_uchida@netjoy.ne.jp

  Affiliation Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

  ⨯